Gujarat Terce Laboratories Ltd

NSE: GUJTERC · BSE: 524314 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹37.81
Market cap: ₹28.06 Cr
Revenue (annual): ₹47.47 Cr
Net profit (annual): ₹2.20 Cr
P/E (TTM): 13.4×Sector 47.3×
Promoter holding: 40.03%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 3 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Earnings Call 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

21 Aug 2026 16:04 IST BSE

Management Change

Gujarat Terce Laboratories Management Change

Gujarat Terce Laboratories issued a corrigendum clarifying the re-appointment tenure of its MD & CEO, Mr. Aalap Prajapati, as three years instead of five.

Read the filing ↗

29 May 2026 22:31 IST BSE

Management Change

Gujarat Terce Laboratories Management Change

Gujarat Terce Laboratories re-appointed Aalap Prajapati as MD & CEO for five years starting October 2026. The move ensures leadership continuity for the pharmaceutical firm.

Execution: 5 years

Read the filing ↗